Results 131 to 140 of about 2,820,603 (281)

Nine controversial questions about augmentation therapy for alpha-1 antitrypsin deficiency: a viewpoint. [PDF]

Eur Respir Rev, 2023
Miravitlles M, Anzueto A, Barrecheguren M.   +2 more
europepmc   +1 more source

Neuropathic bladder and augmentation cystoplasty

, 2018
Surgical indications for individuals with neuropathic bladder include unsafe urinary storage pressures, progressive upper tract deterioration, and continued urinary incontinence that is recalcitrant to oral pharmacologic or intradetrusor injection ...
Roth, Joshua, Cain, Mark P.
core   +1 more source

From Lab to Landscape: Environmental Biohybrid Robotics for Ecological Futures

Advanced Robotics Research, EarlyView.
This Perspective explores environmental biohybrid robotics, integrating living tissues, microorganisms, and insects for operation in real‐world ecosystems. It traces the leap from laboratory experiments to forests, wetlands, and urban environments and discusses key challenges, development pathways, and opportunities for ecological monitoring and ...
Miriam Filippi
wiley   +1 more source

Clinical dilemma of mood stabilizer augmentation in treatment‐resistant schizophrenia with residual phase: A case report of valproate‐associated hypoglycemia and cytopenia, and subsequent lithium response

PCN Reports
Background Mood stabilizer augmentation is frequently used in treatment‐resistant schizophrenia despite limited guideline recommendations. Evidence for its efficacy and safety in the residual phase, however, remains insufficient.
Yoshiki Kasagi, Naomichi Okamoto, Reiji Yoshimura   +2 more
doaj   +1 more source

Comparison of analgesic therapies in traumatic vertebral compression fractures: Vertebroplasty and kyphoplasty versus thermal facet ablation—a prospective randomized trial

North American Spine Society Journal
: Background: Vertebral augmentation techniques are common for painful vertebral compression fractures (VCFs). Radiofrequency thermal facet ablation (RFA) is a potential alternative analgesic therapy, but comparative data remains limited.
Tamás Tóth, MD, Kerim Watfa, MD, Márton Balázsfi, MD, Pál Barzó, MD, PhD, DSc   +3 more
doaj   +1 more source

The augmentation of cognitive behavioural therapy with fluoxetine for the treatment of adolescent school refusal: A randomised controlled trial

, 2012
The augmentation of cognitive behavioural therapy with fluoxetine for the treatment of adolescent school refusal: A randomised controlled ...
Glenn Melvin (13084626), Amanda Dudley (13056630), BJ Tonge (13120197), K Clarke (7756586), MS Gordon (14447658)   +4 more
core  

Coixenolide Enhances Antitumor Immunity of Cytotoxic CD8+ T Cells by Inhibiting S100A8/A9‐CD36 Axis in Obesity‐Associated Pancreatic Adenocarcinoma

Advanced Science, EarlyView.
Pancreatic adenocarcinoma (PAAD) remains highly lethal with limited treatment options. This study demonstrates that coixenolide, a bioactive compound from Coix lacryma‐jobi L. and a key component of the clinically approved Kanglaite injection, exhibits enhanced antitumor efficacy in high‐fat diet (HFD)‐induced obese mice bearing PAAD tumors compared to
Kaidi Chen, Rong Chen, Wei Li, Bin Song, Ruiying Zhang, Lewei Dai, Yuwei Qi, Ruqian Chen, Yifan Xu, Hangbin Li, Jingyi Huang, Fangping Wu, Jianan Peng, Xinyu Wang, Yang Xiong, Chaofeng Mu, Guilin Cheng, Zhaoshen Li, Shanming Ruan, Lei Huang, Mancang Gu   +20 more
wiley   +1 more source

Rab1A Promotes Hepatic Steatosis by Suppressing Mitophagy via the Raf‐1/ERK1/2/PINK1 Signaling Axis

Advanced Science, EarlyView.
Why does fat accumulate in the liver? Our study reveals Rab1A as the molecular switch that silences the cell's mitochondrial cleanup crew. Turning Rab1A off reactivates mitophagy, clears excess fat, and reverses fatty liver disease in mice—offering a promising new therapeutic target for MASLD, a growing global health challenge.
Li Zhang, Jianhua Li, Huilu Zhang, Qi Qin, Yichen Huang, Xiaofan Tian, Chao Sun, Binbin Li, Zhengxin Wang, Xin Zhang   +9 more
wiley   +1 more source

Augmentation strategies in patients with refractory depression

, 1996
In the evaluation of treatment‐resistant or treatment‐refractory depression (TRD), true resistance to antidepressant therapy must be distinguished from inadequate dose, duration, or compliance with past antidepressant therapy.
Nemeroff, Charles B
core   +1 more source

Agmatine augmentation in treatment-resistant obsessive-compulsive disorder: a prospective open-label case series

Frontiers in Psychiatry
ImportanceObsessive-compulsive disorder (OCD) remains treatment-resistant in 40-60% of patients despite adequate trials of serotonin reuptake inhibitors and cognitive behavioral therapy.
Joshua D. Salvi, Joshua D. Salvi
doaj   +1 more source